DrugMapper
Browse
Therapeutic Area
CANCER (51)
CARDIOVASCULAR (45)
DENTISTRY (2)
DERMATOLOGY (31)
DIABETES DRUGS & ENDOCRINOLOGY (61)
EMERGENCY MEDICINE (3)
ENT (5)
EYE (23)
GASTROINTESTINAL (29)
HEMATOLOGY (23)
MUSCULOSKELETAL (28)
NEUROLOGY DRUGS & NERVOUS SYSTEM (50)
PEDIATRICS (27)
PHARMACOLOGY (8)
PREGNANCY AND GYNECOLOGY (30)
RESPIRATORY (42)
RHEUMATOLOGY (19)
OTHER (1482)
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Primary Target
Target Level
Level 1
Level 2
Level 3
Level 4
Level 5
Level 6
Active Pharmaceutical Ingredients (APIs)
Small Molecules
ProDrugs
Antibodies
CNS drugs
Metabolites
Search
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Target Sequence
Chemical Structure
Physicochemical Properties
Analyze
Networks
Chemical Similarity
Scaffold Similarity
KNIME workflow
Downloads
Web services
Bulk Downloads
About
DrugMapper FAQs
Data Sources
Contact Us
Display Options:
Drug type
Therapeutic Area
Route of administration
Mechanism of Action
Indication
Status
Total:
10647
AMINOSALICYLATE SODIUM; AMINOSALICYLIC ACID
4
Combination
Approved
OTHER
ORAL
Unknown
Unknown
AMINOSALICYLATE SODIUM; AMINOSALICYLIC ACID
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
FLUINDIONE
4
Small molecule
Approved
Unknown
Unknown
Thrombosis
Unknown
FLUINDIONE
×
Maximum Phase:
4
First Approval:
None
UNII:
EQ35YMS20Q
Molecule Type:
Small molecule
Molecular Formula:
C15H9FO2
Molecular Weight:
240.23
AlogP:
2.99
PSA:
34.14
HBD:
0.0
HBA:
#RotB:
1.0
Source:
PRONETALOL
4
Small molecule
Approved
Unknown
Unknown
Unknown
Beta-1 adrenergic receptor antagonist
PRONETALOL
×
Maximum Phase:
4
First Approval:
None
UNII:
XBP4RT1IMQ
Molecule Type:
Small molecule
Molecular Formula:
C15H19NO
Molecular Weight:
229.32
AlogP:
2.87
PSA:
32.26
HBD:
2.0
HBA:
#RotB:
4.0
Source:
VARIVAX
4
Unknown
Approved
Unknown
Unknown
Unknown
Unknown
VARIVAX
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
SERTINDOLE
4
Small molecule
Unknown
Unknown
Unknown
Anxiety; Dementia; Depressive Disorder; Schizophrenia; Psychotic Disorders
Adrenergic receptor alpha-1 antagonist
SERTINDOLE
×
Maximum Phase:
4
First Approval:
None
UNII:
GVV4Z879SP
Molecule Type:
Small molecule
Molecular Formula:
C24H26ClFN4O
Molecular Weight:
440.95
AlogP:
4.63
PSA:
40.51
HBD:
1.0
HBA:
#RotB:
5.0
Source:
KETANSERIN
4
Small molecule
Approved
Unknown
Unknown
Diabetic Foot; Acute Kidney Injury; Hypertension
Unknown
KETANSERIN
×
Maximum Phase:
4
First Approval:
None
UNII:
97F9DE4CT4
Molecule Type:
Small molecule
Molecular Formula:
C22H22FN3O3
Molecular Weight:
395.43
AlogP:
2.42
PSA:
75.17
HBD:
1.0
HBA:
#RotB:
5.0
Source:
DIBENZEPIN
4
Small molecule
Approved
Unknown
Unknown
Depressive Disorder
Histamine H1 receptor antagonist
DIBENZEPIN
×
Maximum Phase:
4
First Approval:
None
UNII:
510SJZ1Y6L
Molecule Type:
Small molecule
Molecular Formula:
C18H21N3O
Molecular Weight:
295.39
AlogP:
2.98
PSA:
26.79
HBD:
0.0
HBA:
#RotB:
3.0
Source:
INSULIN LISPRO RECOMBINANT
4
Protein
Approved
DIABETES DRUGS & ENDOCRINOLOGY; OTHER
INJECTION; SUBCUTANEOUS
Unknown
Unknown
INSULIN LISPRO RECOMBINANT
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Protein
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
TEZEPELUMAB-EKKO
4
Unknown
Approved
Unknown
Unknown
Unknown
Unknown
TEZEPELUMAB-EKKO
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
TENOXICAM
4
Small molecule
Approved
Unknown
Unknown
Pain; Rheumatic Diseases
Unknown
TENOXICAM
×
Maximum Phase:
4
First Approval:
None
UNII:
Z1R9N0A399
Molecule Type:
Small molecule
Molecular Formula:
C13H11N3O4S2
Molecular Weight:
337.38
AlogP:
1.64
PSA:
99.6
HBD:
2.0
HBA:
#RotB:
2.0
Source:
SELBEX
4
Unknown
Approved
Unknown
Unknown
Unknown
Unknown
SELBEX
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
CALCIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM CHLORIDE
4
Combination
Approved
OTHER
INJECTION; IRRIGATION
Unknown
Unknown
CALCIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM CHLORIDE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
PARALDEHYDE
4
Small molecule
Approved
Unknown
Unknown
Status Epilepticus
Unknown
PARALDEHYDE
×
Maximum Phase:
4
First Approval:
None
UNII:
S6M3YBG8QA
Molecule Type:
Small molecule
Molecular Formula:
C6H12O3
Molecular Weight:
132.16
AlogP:
1.09
PSA:
27.69
HBD:
0.0
HBA:
#RotB:
0.0
Source:
ROSOXACIN
4
Small molecule
Approved
Unknown
Unknown
Bacterial Infections
Unknown
ROSOXACIN
×
Maximum Phase:
4
First Approval:
None
UNII:
3Y1OT3J4NW
Molecule Type:
Small molecule
Molecular Formula:
C17H14N2O3
Molecular Weight:
294.31
AlogP:
2.78
PSA:
72.19
HBD:
1.0
HBA:
#RotB:
3.0
Source:
SIMVASTATIN; SITAGLIPTIN PHOSPHATE
4
Combination
Approved
DIABETES DRUGS & ENDOCRINOLOGY; OTHER
ORAL
Unknown
Unknown
SIMVASTATIN; SITAGLIPTIN PHOSPHATE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
TERIZIDONE
4
Small molecule
Approved
Unknown
Unknown
Tuberculosis; Tuberculosis, Multidrug-Resistant
Unknown
TERIZIDONE
×
Maximum Phase:
4
First Approval:
None
UNII:
1199LEX5N8
Molecule Type:
Small molecule
Molecular Formula:
C14H14N4O4
Molecular Weight:
302.29
AlogP:
-0.62
PSA:
101.38
HBD:
2.0
HBA:
#RotB:
4.0
Source:
TOLNAFTATE
4
Small molecule
Approved
Unknown
Unknown
Eczema; Infections; Pruritus; Tinea; Tinea Pedis
Unknown
TOLNAFTATE
×
Maximum Phase:
4
First Approval:
None
UNII:
06KB629TKV
Molecule Type:
Small molecule
Molecular Formula:
C19H17NOS
Molecular Weight:
307.42
AlogP:
4.95
PSA:
12.47
HBD:
0.0
HBA:
#RotB:
2.0
Source:
ACRIFLAVINE
4
Small molecule
Approved
Unknown
Unknown
Unknown
Unknown
ACRIFLAVINE
×
Maximum Phase:
4
First Approval:
None
UNII:
1T3A50395T
Molecule Type:
Small molecule
Molecular Formula:
C27H25ClN6
Molecular Weight:
468.99
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
MAGNESIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE
4
Combination
Approved
OTHER
INJECTION
Unknown
Unknown
MAGNESIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ROTARIX
4
Unknown
Approved
Unknown
Unknown
Unknown
Unknown
ROTARIX
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
NIFUROXAZIDE
4
Small molecule
Approved
Unknown
Unknown
Unknown
Unknown
NIFUROXAZIDE
×
Maximum Phase:
4
First Approval:
None
UNII:
PM5LI0P38J
Molecule Type:
Small molecule
Molecular Formula:
C12H9N3O5
Molecular Weight:
275.22
AlogP:
1.66
PSA:
117.97
HBD:
2.0
HBA:
#RotB:
4.0
Source:
PROPATYL NITRATE
4
Small molecule
Approved
Unknown
Unknown
Cardiovascular Diseases
Unknown
PROPATYL NITRATE
×
Maximum Phase:
4
First Approval:
None
UNII:
AJT2YN495R
Molecule Type:
Small molecule
Molecular Formula:
C6H11N3O9
Molecular Weight:
269.17
AlogP:
0.01
PSA:
157.11
HBD:
0.0
HBA:
#RotB:
10.0
Source:
DIHYDROSTREPTOMYCIN SULFATE
4
Small molecule
Approved
Unknown
Unknown
Unknown
Bacterial 70S ribosome inhibitor
DIHYDROSTREPTOMYCIN SULFATE
×
Maximum Phase:
4
First Approval:
None
UNII:
T7D4876IUE
Molecule Type:
Small molecule
Molecular Formula:
C42H88N14O36S3
Molecular Weight:
1461.43
AlogP:
-7.95
PSA:
334.59
HBD:
15.0
HBA:
#RotB:
9.0
Source:
PENTETATE CALCIUM TRISODIUM YB-169
4
Small molecule
Approved
OTHER
INJECTION
Unknown
Unknown
PENTETATE CALCIUM TRISODIUM YB-169
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
MAGNESIUM PIDOLATE
4
Small molecule
Approved
Unknown
Unknown
Anemia, Sickle Cell; Hemoglobin SC Disease
Unknown
MAGNESIUM PIDOLATE
×
Maximum Phase:
4
First Approval:
None
UNII:
V5PC588N7G
Molecule Type:
Small molecule
Molecular Formula:
C10H12MgN2O6
Molecular Weight:
280.52
AlogP:
-0.65
PSA:
66.4
HBD:
2.0
HBA:
#RotB:
1.0
Source:
DEXTROSE; POTASSIUM CHLORIDE; POTASSIUM PHOSPHATE, DIBASIC; SODIUM ACETATE; SODIUM CHLORIDE
4
Combination
Approved
OTHER
INJECTION
Unknown
Unknown
DEXTROSE; POTASSIUM CHLORIDE; POTASSIUM PHOSPHATE, DIBASIC; SODIUM ACETATE; SODIUM CHLORIDE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
CARBETOCIN
4
Protein
Unknown
Unknown
Unknown
Postpartum Hemorrhage; Prader-Willi Syndrome
Oxytocin receptor agonist
CARBETOCIN
×
Maximum Phase:
4
First Approval:
None
UNII:
88TWF8015Y
Molecule Type:
Protein
Molecular Formula:
C45H69N11O12S
Molecular Weight:
988.18
AlogP:
-2.5
PSA:
362.51
HBD:
10.0
HBA:
#RotB:
18.0
Source:
SODIUM FERRIC GLUCONATE
4
Unknown
Approved
Unknown
Unknown
Unknown
Unknown
SODIUM FERRIC GLUCONATE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
AMINO ACIDS; MAGNESIUM ACETATE; PHOSPHORIC ACID; POTASSIUM ACETATE; POTASSIUM CHLORIDE; SODIUM ACETATE
4
Combination
Approved
OTHER
INJECTION
Unknown
Unknown
AMINO ACIDS; MAGNESIUM ACETATE; PHOSPHORIC ACID; POTASSIUM ACETATE; POTASSIUM CHLORIDE; SODIUM ACETATE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
LEDIPASVIR; SOFOSBUVIR
4
Combination
Approved
UROLOGY AND KIDNEY
ORAL
Unknown
Unknown
LEDIPASVIR; SOFOSBUVIR
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ETHYNODIOL DIACETATE; MESTRANOL
4
Combination
Approved
OTHER
ORAL-20; ORAL-21; ORAL-28
Unknown
Unknown
ETHYNODIOL DIACETATE; MESTRANOL
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
AMINO ACIDS; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; POTASSIUM PHOSPHATE, DIBASIC; SODIUM CHLORIDE
4
Combination
Approved
OTHER
INJECTION
Unknown
Unknown
AMINO ACIDS; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; POTASSIUM PHOSPHATE, DIBASIC; SODIUM CHLORIDE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ESTRADIOL HEMIHYDRATE
4
Small molecule
Approved
OTHER
TOPICAL
Unknown
Unknown
ESTRADIOL HEMIHYDRATE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
AMMONIA N-13
4
Small molecule
Approved
OTHER
INTRAVENOUS
Unknown
Unknown
AMMONIA N-13
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ETHINYL ESTRADIOL; NORETHINDRONE
4
Combination
Approved
OTHER
ORAL; ORAL-21; ORAL-28
Unknown
Unknown
ETHINYL ESTRADIOL; NORETHINDRONE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
1
2
…
259
260
261
262
263
264
265
…
304
305
Next »
Download Option
Close
Header
Compound Name
Maximum Phase
Compound Structure
Smile
Inchi
InchiKey
Compound Properties
Molecular Formula
Molecular Weight
ALogP
PSA